Related company info
Press release, January 20; Joseph Tsai, DIGITIMES
Tuesday 20 January 2009
  • Biostar Microtech International
  • Performance
    The company's stock price closed at NT$15.8 on the TSE on Thursday, June 21, 2018.
    The company has reported consolidated revenues of NT$270 million for May 2018, representing a 14% increase on month and 20.9% drop on year.
    For the first quarter of 2018, the company totaled NT$1,036 million in consolidated revenues, up 27.2% sequentially and up 33.1% on year.
    Brief

    Full name: Biostar Microtech International

    Chinese name: 映泰股份有限公司

    Short name: Biostar

    Stock code: 2399

    Tax ID: 23826200

    Market: TSE

    Established: 29 Aug 1990

    Paid in capital: NT$1.78 billion

    Listed on TSE: 16 Dec 1999

    Website: www.biostar.com.tw

  • On display

    Biostar iMiner series

    Biostar G41 chipset motherboard

    Biostar TA790GX A3+ motherboard

  • Latest stock
    Biostar [2399] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    22-Jun 2,890 1,351 43,755,200 15.70 15.75 14.85 14.85-0.95-6.01% 14.85 14.90
    21-Jun 1,469 766 23,432,853 16.05 16.30 15.75 15.80-0.20-1.25% 15.80 15.85
    20-Jun 3,655 1,152 59,396,650 16.50 16.60 15.95 16.00-0.50-3.03% 16.00 16.10
    19-Jun 1,497 718 24,912,241 16.90 16.90 16.50 16.50-0.45-2.65% 16.50 16.55
    15-Jun 5,424 1,610 93,875,850 16.85 17.50 16.85 16.95+0.15+0.89% 16.95 17.05
    14-Jun 1,206 572 20,446,350 17.15 17.15 16.80 16.80-0.15-0.88% 16.80 16.85
    • Source: TSE, compiled by Digitimes
    Latest sales

    Biostar: Consolidated revenues, May 2017 - May 2018 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    May-18

    270

    14%

    (20.9%)

    1,542

    14.7%

    Apr-18

    237

    (35.1%)

    5.1%

    1,272

    26.8%

    Mar-18

    364

    37%

    14.3%

    1,036

    33.1%

    Feb-18

    266

    (34.4%)

    5.4%

    671

    46.1%

    Jan-18

    405

    5.4%

    95.6%

    405

    95.6%

    Dec-17

    385

    64.3%

    72.1%

    3,443

    14.9%

    Nov-17

    234

    20%

    (12.2%)

    3,059

    10.3%

    Oct-17

    195

    (18.4%)

    (20%)

    2,824

    12.7%

    Sep-17

    239

    (1.9%)

    (14%)

    2,629

    16.2%

    Aug-17

    244

    (30.2%)

    (3.9%)

    2,390

    20.4%

    Jul-17

    349

    (22.9%)

    47.5%

    2,146

    24%

    Jun-17

    453

    32.7%

    75.6%

    1,797

    20.3%

    May-17

    341

    51.5%

    56.7%

    1,345

    8.7%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

    Biostar: Consolidated revenues, 1Q17 - 1Q18 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    1Q-18

    1,036

    27.2%

    33.1%

    1,036

    33.1%

    4Q-17

    814

    (2.2%)

    10.8%

    3,443

    14.9%

    3Q-17

    832

    (18.3%)

    8.3%

    2,629

    16.2%

    2Q-17

    1,019

    30.9%

    42.1%

    1,797

    20.3%

    1Q-17

    778

    6%

    0.1%

    778

    0.1%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

    Latest balance sheet and income statement

    Biostar: Consolidated balance sheet, 1Q17 - 1Q18 (NT$k)

    Item

    1Q-2018

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    Current assets

    2,902,121

    2,853,342

    2,740,256

    2,734,762

    2,539,657

    Intangible assets

    171,024

    171,024

    0

    Non-current assets

    946,358

    851,730

    602,105

    555,881

    564,099

    Assets

    3,848,479

    3,705,072

    3,342,361

    3,290,643

    3,103,756

    Current liabilities

    1,058,112

    1,004,265

    887,094

    904,946

    790,561

    Non-current liabilities

    69,109

    69,436

    62,373

    56,774

    67,841

    Liabilities

    1,127,221

    1,073,701

    949,467

    961,720

    858,402

    Stockholders' equity

    2,721,258

    2,631,371

    2,392,894

    2,328,923

    2,245,354

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

    Biostar: Consolidated income statement, 1Q17 - 1Q18 (NT$k)

    Item

    1Q-2018

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    1,035,770

     

    814,150

     

    832,114

     

    1,018,721

     

    778,407

     

    Gross profit (loss) from operations

    199,248

    19.2%

    89,075

    10.9%

    133,723

    16.1%

    142,850

    14%

    89,536

    11.5%

    Operating expenses

    99,672

    9.6%

    94,861

    11.7%

    88,699

    10.7%

    79,736

    7.8%

    99,463

    12.8%

    Operating income (loss)

    99,576

    9.6%

    -5,786

    -0.7%

    45,024

    5.4%

    63,114

    6.2%

    -9,927

    -1.3%

    Non-operating expenses and losses

    -10,850

    -1%

    -7,328

    -0.9%

    15,581

    1.9%

    20,655

    2%

    -30,700

    -3.9%

    Income from continuing operations before income tax

    88,726

    8.6%

    -13,114

    -1.6%

    60,605

    7.3%

    83,769

    8.2%

    -40,627

    -5.2%

    Net income (loss)

     

     

    -228

    0%

    58,635

    7%

    81,864

    8%

    -35,337

    -4.5%

    Diluted earnings per share (NT$)

    0.4

     

    -0

     

    0.3

     

    0.5

     

    -0.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

Taiwan handsets – 1Q 2018

Taiwan LCD TVs – 1Q 2018

Taiwan LCD monitors – 1Q 2018

Global AP market, 2017-2021

Taiwan server shipment forecast and industry analysis, 2018

China AMOLED panel capacity expansion forecast, 2016-2020

© DIGITIMES Inc. All rights reserved.
Please do not republish, publicly broadcast or publicly transmit content from this website without written permission from DIGITIMES Inc. Please contact us if you have any questions.